logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Michael Untch

helios klinikum berlin-buch

108H指数
1.4K论文数
7.2W被引数
收录论文 315
发表时间
logo
Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial早期乳腺癌中临床医生报告的毒性与患者报告的症状严重程度的一致性：对随机III期PANTHER试验的分析
errESMO Open
IF8.3
err2026-05-09
err0
errOAAI
errP. Filis; X. Liu; A. Matikas; M. Untch; G.G. Steger; H. Johansson; M. Hellström; M. Gnant; S. Loibl; Y. Brandberg; J. Bergh; T. Foukakis
err分享
err收藏
Ribosomal RNA Degradation (RNA Disruption) in Tumour Cells: Mechanistic Insights and Potential Clinical Utility肿瘤细胞中的核糖体RNA降解（RNA解聚）：机制见解与潜在临床应用
errCancers
IF4.4
err2026-03-03
err0
errOAAI
errAmadeo M. Parissenti; Sanaa Noubir; Laura B. Pritzker; Thomas Kovala; Carita Lannér; Jennifer Lemon; Tunde Onayemi; Sreepriya Pk; Gabriel Thériault; Maureen E. Trudeau; Michael M. Untch
err分享
err收藏
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials远处无病生存期作为早期乳腺癌新辅助治疗随机试验中总生存期的替代终点：GBG和AGO-B研究组试验的合并分析
errThe Lancet Oncology
IF0
err2025-11-24
err0
PREAI
errFabio Conforti; Johannes Holtschmidt; Valentina Nekljudova; Isabella Sala; Eleonora Pagan; Christine Solbach; Michael Untch; Carsten Denkert; Vincenzo Bagnardi; Laura Pala; Peter A Fasching; Andreas Schneeweiss; Hans-Joachim Lück; Giuseppe Viale; Tommaso De Pas; Marion van Mackelenbergh; Jens Huober; Volkmar Müller; Theresa Link; Thomas Karn
err分享
err收藏
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival☆HR阳性/HER2阴性早期乳腺癌患者的辅助瑞博西lib联合非甾体类芳香化酶抑制剂治疗：NATALEE试验5年随访的有效性结局及更新后的总生存期☆
errESMO Open
IF8.3
err2025-10-17
err0
errOAAI
errJ. Crown; D. Stroyakovskii; D.A. Yardley; C.-S. Huang; P.A. Fasching; A. Bardia; S. Chia; S.-A. Im; M. Martin; B. Xu; C.H. Barrios; M. Untch; R. Moroose; S.A. Hurvitz; G.N. Hortobagyi; D.J. Slamon; F. Visco; G. Spera; J.P. Zarate; D. Halligan; Z. Li; S. Loi
err分享
err收藏
Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based study乳腺癌患者接受阿贝西利或瑞博西利辅助治疗的患病率与预后：一项全国性基于人群的研究
errThe Lancet Regional Health - Europe
IF0
err2025-09-29
err0
errOAAI
errXingrong Liu; Behnaz Binicy; Balazs Acs; Louise Eriksson Bergman; Sibylle Loibl; Michael Gnant; Michael Untch; Antonios Valachis; Jonas Bergh; Johan Hartman; Theodoros Foukakis; Alexios Matikas
err分享
err收藏
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025AGO乳腺癌委员会关于乳腺癌手术治疗的建议：妇科肿瘤工作组（AGO）2025年更新
errEuropean Journal of Surgical Oncology
IF2.9
err2025-09-17
err0
PREAI
errToralf Reimer; Thorsten Kuehn; Volkmar Mueller; Nina Ditsch; Tanja Fehm; Ute-Susann Albert; Rupert Bartsch; Ingo Bauerfeind; Vesna Bjelic-Radisic; Jens-Uwe Blohmer; Wilfried Budach; Peter Dall; Eva Maria Fallenberg; Peter A. Fasching; Michael Friedrich; Bernd Gerber; Oleg Gluz; Nadia Harbeck; Andreas Hartkopf; Joerg Heil; Juliane Hoerner-Rieber; Jens Huober; Wolfgang Janni; Hans-Heinrich Kreipe; David Krug; Sherko Kuemmel; Sibylle Loibl; Diana Lueftner; Michael Patrick Lux; Nicolai Maass; Christoph Mundhenke; Tjoung-Won Park-Simon; Mattea Reinisch; Kerstin Rhiem; Achim Rody; Marcus Schmidt; Andreas Schneeweiss; Florian Schuetz; Hans-Peter Sinn; Christine Solbach; Erich-Franz Solomayer; Elmar Stickeler; Christoph Thomssen; Michael Untch; Marion van Mackelenbergh; Isabell Witzel; Achim Woeckel; Rachel Wuerstlein; Maggie Banys-Paluchowski; Marc Thill
err分享
err收藏
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer在接受一线CDK4/6抑制剂治疗后，转移性激素受体阳性、HER2阴性乳腺癌患者选择化疗方案的预后影响
errEuropean Journal of Cancer
IF7.1
err2025-08-05
err0
errOAAI
errLaura L. Michel; Philipp Ziegler; Philipp Kreis; Andreas D. Hartkopf; Markus Wallwiener; Lothar Häberle; Nelson John; Hans-Christian Kolberg; Peyman Hadji; Hans Tesch; Johannes Ettl; Diana Lüftner; Volkmar Müller; Erik Belleville; Pauline Wimberger; Hans-Martin Enzinger; Hanna Huebner; Sabrina Uhrig; Carolin C. Hack; Petra Krabisch; Peter A. Fasching; Rachel Wuerstlein; Michael Untch; Nina Ditsch; Alexander Hein; Wolfgang Janni; Florin-Andrei Taran; Michael P. Lux; Diethelm Wallwiener; Sara Y. Brucker; Tanja N. Fehm; Andreas Schneeweiss; Chloë Goossens; Tobias Engler
err分享
err收藏
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy☆PENELOPE-B试验的最终生存结果，该试验探讨了帕博西利（palbociclib）与安慰剂对比用于新辅助化疗后具有高危HR+/HER2−乳腺癌且存在残留病灶患者的治疗。
errAnnals of Oncology
IF65.4
err2025-03-24
err0
PREAI
errS. Loibl; M. Martin; H. Bonnefoi; M. Untch; S.-B. Kim; H.D. Bear; J.A. García-Sáenz; M. Melé Olivé; N. Mc Carthy; K. Gelmon; C.M. Kelly; S.-A. Im; T. Reimer; M. Martinez-Janez; Z. Zhang; M. Toi; L. Provencher; H.S. Rugo; M. Gnant; A. Makris; F. Marmé
err分享
err收藏
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2025-02-20
err0
PREAI
errBanys-Paluchowski, Maggie; Hartmann, Steffi; Basali, Timo; Gasparri, Maria Luisa; de Boniface, Jana; Gentilini, Oreste Davide; Cakmak, Gueldeniz Karadeniz; Ditsch, Nina; Stickeler, Elmar; Schlichting, Ellen; Rubio, Isabel; Peintinger, Florentia; Untch, Michael; Mau, Christine; Federspiel, Frederike Klaassen; Bucher, Susanne; Ramaker, Kerstin; Paluchowski, Peter; Bauer, Lelia; Riemer, Sabine; Langanke, Dagmar; Leuf, Tanja Durpektova; Schnabel, Jens; von Abel, Ekkehard; Solbach, Christine; Ovalle, Sonja Caradenas; Hilmer, Kerstin; Bjelic-Radisic, Vesna; Stahl, Nicole; Sanchez-Mendez, Jose I.; Hagen, Vibeke; Hansen, Marit Helene; Krawczyk, Natalia; Sezen, Bilge Aktas; Jursik, Katharina; Thill, Marc; Kolberg, Hans-Christian; Reimer, Toralf; Ruf, Franziska; Wihlfahrt, Kristina; Rief, Angelika; Berger, Tomasz; Schmidt, Esther; Tauber, Nikolas; Froehlich, Sarah; Kuehn, Thorsten
err分享
err收藏
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial乳腺癌辅助化疗中从剂量密集方案获益：来自随机III期PANTHER试验的亚组分析
errLANCET REGIONAL HEALTH-EUROPE
IF13
err2025-02-01
err1
PREAI
errMatikas, Alexios; Papakonstantinou, Andri; Loibl, Sibylle; Steger, Guenther G.; Untch, Michael; Johansson, Hemming; Hellstrom, Mats; Greil, Richard; Moebus, Volker; Gnant, Michael; Bergh, Jonas
err分享
err收藏
Efficacy and safety of ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) in older patients (pts) with HR+/HER2-early breast cancer (EBC) in NATALEE来那替尼（RIB）联合非甾体类芳香化酶抑制剂（NSAI）在NATALEE研究中，对激素受体阳性、人表皮生长因子受体2阴性早期乳腺癌（EBC）老年患者（pts）的疗效与安全性。
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errUntch, M.; Yardley, D.; Im, S-A.; Pluard, T.; Hart, L.; Crown, J. P.; Freyer, G.; Zamagni, C.; Lopez-Barajas, I. Blancas; Parnizari, F.; Gao, M.; Amin, K.; Hu, H.; Rugo, H. S.
err分享
err收藏
Neoadjuvant chemotherapy in inflammatory breast cancer: A meta-analysis of 10 trials of the German Breast Group (GBG)炎性乳腺癌的新辅助化疗：德国乳腺癌组（GBG）10项试验的Meta分析
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errMichel, L.; Untch, M.; Schneeweiss, A.; Solbach, C.; Blohmer, J-U.; Fasching, P. A.; Wimberger, P.; Hanusch, C.; Rezai, M.; Denkert, C.; Lueck, H-J.; Huober, J.; Schmatloch, S.; Rhiem, K. E.; Just, M.; Link, T.; Ladda, E.; Rey, J.; Holtschmidt, J.; Loibl, S.
err分享
err收藏
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
errNPJ BREAST CANCER
IF7.6
err2024-07-13
err0
errOAAI
errFasching, Peter A.; Hu, Chunling; Hart, Steven N.; Ruebner, Matthias; Polley, Eric C.; Gnanaolivu, Rohan D.; Hartkopf, Andreas D.; Huebner, Hanna; Janni, Wolfgang; Hadji, Peyman; Tesch, Hans; Uhrig, Sabrina; Ettl, Johannes; Lux, Michael P.; Lueftner, Diana; Wallwiener, Markus; Wurmthaler, Lena A.; Goossens, Chloe; Mueller, Volkmar; Beckmann, Matthias W.; Hein, Alexander; Anetsberger, Daniel; Belleville, Erik; Wimberger, Pauline; Untch, Michael; Ekici, Arif B.; Kolberg, Hans-Christian; Hartmann, Arndt; Taran, Florin-Andrei; Fehm, Tanja N.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas; Haeberle, Lothar; Couch, Fergus J.
err分享
err收藏
Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2024-06-24
err3
errOAAI
errDent, Rebecca; Cortes, Javier; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Fasching, Peter A.; Cardoso, Fatima; Haiderali, Amin; Jia, Liyi; Nguyen, Allison Martin; Pan, Wilbur; O'Shaughnessy, Joyce; Schmid, Peter
err分享
err收藏
Palbociclib combined with endocrine treatment in hormone receptorpositive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B
errESMO OPEN
IF8.3
err2024-06-01
err1
errOAAI
errMarme, F.; Martin, M.; Untch, M.; Thode, C.; Bonnefoi, H.; Kim, S. b.; Bear, H.; Mc Carthy, N.; Gelmon, K.; Garcia-Saenz, J. A.; Kelly, C. M.; Reimer, T.; Valota, O.; Toi, M.; Rugo, H. S.; Gnant, M.; Makris, A.; Bassy, M.; Zhang, Z.; Furlanetto, J.; Nekljudova, V.; Loibl, S.
err分享
err收藏
CDH1 mutations predict resistance to neoadjuvant taxane therapy
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errKnappskog, Stian; Helwa, Reham; Rachakonda, Sivaramakrishna; Gansmo, Liv B.; Denkert, Carsten; Yates, Lucy R.; Solbach, Christine; Untch, Michael; Sinn, Bruno V.; Litmeyer, Anne-Sophie; Ataseven, Beyhan; Huober, Jens; Wedge, David C.; Karn, Thomas; Nikolaienko, Oleksii; Marme, Frederik; Fasching, Peter A.; Eikesdal, Hans Petter; Stickeler, Elmar; Schem, Christian; Jank, Paul; van Mackelenbergh, Marion; Muller, Volkmar; Felder, Baerbel; Holtschmidt, Johannes; Campbell, Peter J.; Loibl, Sibylle; Lonning, Per
err分享
err收藏
Ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) as adjuvant treatment in patients with HR+/HER2-early breast cancer: final invasive disease-free survival (iDFS) analysis from the NATALEE trial
errCANCER RESEARCH
IF16.6
err2024-05-02
err3
PREAI
errHortobagyi, Gabriel; Stroyakovsky, Daniil; Yardley, Denise; Huang, Chiun-Shen; Fasching, Peter A.; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Martin, Miguel; Loi, Sherene; Xu, Binghe; Hurvitz, Sara; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Parnizari, Federico; Ghaznawi, Farhat; Li, Zheng; Waters, Sorcha; Chakravartty, Arunava; Slamon, Dennis
err分享
err收藏
SerMa (Seroma of the Mammary gland) pilot - Is there a possible link between macrophage-based immune response and age?
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errKoepke, Melitta; Schneider, Felicitas; Kuhn, Christina; Wild, Mathis; Schneider, Mariella; Pochert, Nicole; Traidl-Hoffmann, Claudia; Sagasser, Jacqueline; Dannecker, Christian; Hinske, Christian; Banys-Paluchowski, Maggie; Untch, Michael; Kuhn, Thorsten; Jeschke, Udo; Ditsch, Nina
err分享
err收藏
Germline mutation status of BRCA1/2 and other breast cancer predisposition genes as predictive and prognostic biomarker: Results of the GeparX study (GeparX-BRCA)
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errSchmutzler, Rita K.; Link, Theresa; Hahnen, Eric; Reinisch, Mattea; Hauke, Jan; Just, Marianne; Untch, Michael; Ernst, Corinna; Stotzer, Oliver; Fasching, Peter A.; Kayali, Mohamad; Wimberger, Pauline; Schneeweiss, Andreas; Schmidt, Sandra; Seiler, Sabine; Jackisch, Christian; Thill, Marc; Rhiem, Kerstin; Denkert, Carsten; Nekljudova, Valentina; Holtschmidt, Johannes; Blohmer, Jens-Uwe; Loibl, Sibylle
err分享
err收藏
Phase III study of adjuvant ado-trastuzumab emtansine vs trastuzumab for residual invasive HER2-positive early breast cancer after neoadjuvant chemotherapy and HER2-targeted therapy: KATHERINE final IDFS and updated OS analysis
errCANCER RESEARCH
IF16.6
err2024-05-02
err8
PREAI
errLoibl, Sibylle; Mano, Max; Untch, Michael; Huang, Chiun-Shen; Mamounas, Eleftherios; Wolmark, Norman; Knott, Adam; Siddiqui, Asna; Boulet, Thomas; Nyawira, Beatrice; Restuccia, Eleonora; Geyer, Charles
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
JoAnn E. Manson
H 指数: 255 · 论文数: 2.7K
H
Hermann Brenner
H 指数: 202 · 论文数: 3.3K
C
Charles M. Perou
H 指数: 193 · 论文数: 2.0K
B
Børge G. Nordestgaard
H 指数: 192 · 论文数: 1.8K
G
Gabriel N. Hortobágyi
H 指数: 187 · 论文数: 1.9K
查看更多